Searchable abstracts of presentations at key conferences in endocrinology

ea0049gp244 | Thyroid Cancer & Thyroid Case Reports | ECE2017

Expressions of miRNAs and BRAFV600E mutation detection in papillary thyroid carcinoma

Simanaviciene Vaida , Kondrotiene Aiste , Pamedytyte Daina , Sarauskas Valdas , Dauksiene Dalia , Dauksa Albertas , Zvirbliene Aurelija , Zilaitiene Birute

Introduction: Papillary thyroid carcinoma (PTC) is the most common type of thyroid malignancy. For the majority of patients with PTC, the prognosis is very good; however, up to 20% of patients suffer disease recurrence. Currently, the risk stratification for PTC recurrence is based on clinicopathological features which have limited prognostic value. Identification of molecular biomarkers of PTC recurrence such as protooncogene BRAF and miRNAs may help to improve risk-stratifie...

ea0049ep164 | Endocrine tumours and neoplasia | ECE2017

Ectopic Cushing’s syndrome caused by a pulmonary adrenocorticotropic hormone secreting tumour: a case report

Pauliukiene Renata , Prakapiene Edita , Koreiviene Rasa , Klimaite Raimonda , Barsiene Lina , Sarauskas Valdas

Introduction: Ectopic adrenocorticotropic hormone (ACTH) production by the pulmonary neuroendocrine tumour (p-NET) is rare, and is considered an aggressive variant of carcinoid tumours with poor prognosis.Case presentation: 59-year-old male with fast progressing generalized fatigue, abdominal discomfort, and diarrhea was hospitalized in gastroenterology unit of Hospital of Lithuanian University of Health Sciences, Kauno klinikos (HLUHS KK). Digestive tra...

ea0049ep839 | Clinical case reports - Pituitary/Adrenal | ECE2017

Pituitary apoplexy while treating recurrence of Cushing’s disease with Pasireotide

Zilaitiene Birute , Kondrotiene Aiste , Verkauskiene Rasa , Barsiene Lina , Knispelis Robertas , Sarauskas Valdas , Colao Annamaria

Introduction: ACTH producing macroadenoma and pituitary apoplexy are rare in Cushing’s disease. Somatostatin receptor agonist Pasireotide is indicated for the treatment of patients with Cushing’s disease for whom surgery is not an option or has failed. We present a case of pituitary apoplexy in patient with recurrence of Cushing’s disease treated with Pasireotide.Case: 38 years old female presented with quick weight gain, weakness, irregul...

ea0041ep1125 | Thyroid cancer | ECE2016

Anaplastic thyroid carcinoma masquerading as subacute thyroiditis

Vainikonyte-Kristapone Jelena , Jakuboniene Neli , Barsiene Lina , Sarauskas Valdas , Kuprionis Gintaras

Anaplastic thyroid carcinoma (ATC) is a rare form of thyroid carcinoma that is associated with an extremely poor prognosis. Ultrasonography (US) and subsequent fine needle aspiration biopsy (FNAB) are the first diagnostic methods in the assessment of a palpable thyroid mass. Nevertheless, some clinical and US features of ATC are not specific. Here, we report on an extremely rare case of ATC masquerading as subacute thyroiditis (SAT).A 40-year-old woman w...

ea0070ep440 | Thyroid | ECE2020

The relationship between clinicopathological factors and recurrence risk of papillary thyroid cancer

Klimaite Raimonda , Dauksiene Dalia , Dauksa Albertas , Sarauskas Valdas , Verkauskiene Rasa , Zilaitiene Birute

Introduction: Papillary thyroid carcinoma (PTC) is the most common type of differentiated thyroid cancer, accounting for about 80% of all cases of thyroid cancer. 20 – year survival rate is about 90%. However, PTC can be aggressive – up to 30% of the patients have local renewal or systemic spread.Our objective was to evaluated the clinicopathological factors of recurrence in completely resected PTC patients.Methods: A r...

ea0056gp229 | Thyroid Cancer - Diagnostics & Treatments | ECE2018

Is thyroid nodule size a factor to consider when deciding for fine-needle aspiration procedure?

Kuprionis Gintaras , Staras Zygimantas , Marcinkute Ugne , Makstiene Jurgita , Sarauskas Valdas , Barsiene Lina

Introduction: Fine-needle aspiration (FNA) is the most accurate diagnostic approach for determining thyroid nodule malignancy. Most nodules are benign, therefore, only suspicious ones require FNA. In 2017 American College of Radiology proposed a scoring system – Thyroid Imaging, Reporting and Data System (TI-RADS) for identifying clinically significant malignancies. Whether a nodule requires FNA depends on various criteria, one of which is the size. The aim of this study ...

ea0056p1173 | Thyroid cancer | ECE2018

Relationship between microRNA expression levels and tumor size in patients with papillary thyroid carcinoma

Pamedytyte Daina , Simanaviciene Vaida , Zvirbliene Aurelija , Kazokaite Mintaute , Sarauskas Valdas , Dauksiene Dalia , Dauksa Arbertas , Zilaitiene Birute

Introduction: Despite low mortality rates of patients with papillary thyroid carcinoma (PTC), disease progression in PTC occurs in up to 20% of patients. Currently, recurrence risk stratification is accomplished by using clinicopathologic factors, despite their limited prognostic value. Some data suggest that patient age at disease onset and primary tumor size may predict the risk of disease progression. Identification of possible associations of traditional clinicopathologica...

ea0070aep931 | Thyroid | ECE2020

Evaluation of miRNA-222, –146b, –181b as possible diagnostic markers in patients with papillary thyroid carcinoma

Kondrotiene Aiste , Pamedytyte Daina , Simanaviciene Vaida , Dauksiene Dalia , Zvirbliene Aurelija , Kazokaite Mintaute , Klimaite Raimonda , Sarauskas Valdas , Daukša Albertas , Verkauskiene Rasa , Zilaitiene Birute

Introduction: The sensitivity and specificity of biomarkers which have been used in clinical practice for diagnosis of papillary thyroid carcinoma (PTC) are low. It is essential to develop novel diagnostic biomarkers for PTC.Objective: We aimed to explore the expression levels of miR-222, – 146b, –181b in PTC tissue and plasma samples and to compare with benign thyroid nodules (BTN).Methods: We collected plasma samples ...